Gianluca Rinaldi,Silvia Fratarcangeli,Michael James Shopik,Alessandra Del Rio
申请号：
US16491502
公开号：
US20200016267A1
申请日:
2018.03.06
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to a novel anti-PD-L1 antibody formulation. In particular, the invention relates to an aqueous pharmaceutical formulation of the anti-PD-L antibody Avelumab.
